Sterol biosynthesis, brain development, and disease
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci208000 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Eric S Peeples und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Brain, Smith-Lemli-Opitz Syndrome, Cholesterol, Sterols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Cholesterol biosynthesis is indispensable for CNS development and function. The developing brain relies almost entirely on intrinsic sterol synthesis to support membrane biogenesis, axonal outgrowth, synaptogenesis, and myelination. Pathogenic variants in sterol biosynthetic enzymes, including DHCR7 and DHCR24, result in complex neurodevelopmental disorders such as Smith-Lemli-Opitz syndrome and desmosterolosis. In addition to cholesterol-lowering drugs (statins), some other pharmacological agents such as antipsychotics, antidepressants, and beta blockers can also inhibit cholesterol biosynthesis due to off-target effects. This inhibition produces dual pathophysiological effects: cholesterol depletion and accumulation of its precursor, 7-dehydrocholesterol, an exceptionally oxidizable molecule that spontaneously generates toxic oxysterols. Given the intense demand for cholesterol synthesis in the developing brain, prenatal exposure to sterol biosynthesis–inhibiting medications may have far-reaching effects. In this Review, we describe convergent biochemical, genetic, and epidemiologic data that implicate developmental sterol dysregulation as a modifiable risk factor for neurodevelopmental pathology and underscore the urgent need for routine sterol pathway safety assessment in drug development and prenatal pharmacotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Child Health Research Institute, Omaha, Nebraska, USA.
- Division of Neonatology, Children's Nebraska, Omaha, Nebraska, USA.
- Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Förderung
- NIMH NIH HHS
- NICHD NIH HHS
Zitieren
APA
Peeples, E. S., Korade, Z., & Mirnics, K. (2026). Sterol biosynthesis, brain development, and disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci208000
Vancouver
Peeples ES, Korade Z, Mirnics K. Sterol biosynthesis, brain development, and disease. Journal of Clinical Investigation. 2026. doi:10.1172/jci208000
BibTeX
@article{Peeples2026,
author = {Peeples, Eric S and Korade, Zeljka and Mirnics, Karoly},
title = {Sterol biosynthesis, brain development, and disease},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci208000}
}
EUVIMED